{"name":"Institut Investigacio Sanitaria Pere Virgili","slug":"institut-investigacio-sanitaria-pere-virgili","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Niacin plus laropiprant","genericName":"Niacin plus laropiprant","slug":"niacin-plus-laropiprant","indication":"Dyslipidemia and mixed dyslipidemia in patients at risk for cardiovascular disease","status":"marketed"}]}],"pipeline":[{"name":"Niacin plus laropiprant","genericName":"Niacin plus laropiprant","slug":"niacin-plus-laropiprant","phase":"marketed","mechanism":"Niacin raises HDL cholesterol and lowers triglycerides, while laropiprant blocks prostaglandin D2 receptors to reduce niacin-induced flushing.","indications":["Dyslipidemia and mixed dyslipidemia in patients at risk for cardiovascular disease"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxOWkdMVDRjbWVtanJoM2hGbmtQRVI1eDZIcndsT0gyaTB0UmlCYlhGVzdEQVpDYXdXU0tpQTExYTRyX05DeVBDY21NbE1QaU5SUWdFM3pRUzh2dnlBT0ZacFVxMGROR3ppZmtlZXJ2c0ZhcFA4TEZSWXJhTTdrMUZKRGx6STRtbGQ5MFVhT0w4amhIRHQtSE56SnFIWXl4emViVFRLdEdJckdVQng1eXhRRDFRaENxZGNicjRxd05Wc2h2ZDlSQzBIa3FoQjJIbjRVRnMtYjdIbDc?oc=5","date":"2024-08-07","type":"pipeline","source":"University of Reading","summary":"Research confirms health benefits of plant oils - University of Reading","headline":"Research confirms health benefits of plant oils","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1zWTA3eUFNVU5oRElWYTRjYUNua0FnRU5LY2JIU3pzUVgtZlZERng5VGVSZC0wd2R4ejlwR21Za0xPaGQtMUt4RUExSENJeWxWYXJBd1FIb3d0MFowYW9v?oc=5","date":"2023-10-02","type":"trial","source":"nature.com","summary":"Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial - nature.com","headline":"Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a ran","sentiment":"positive"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}